SEC Filing Summary
Filing identity: The request metadata identifies Firefly Neuroscience, Inc., but the supplied Form 10-Q is for Information Analysis Incorporated (IAI), a Virginia IT services and software company. Investors should verify the issuer before relying on this summary.
Business context and reporting period
This is IAI’s unaudited quarterly report for the quarter and six months ended June 30, 2013, compared with the corresponding 2012 periods. IAI provides IT modernization, software migration and maintenance, and consulting services to government and commercial customers, with a concentration in the Washington, D.C. area.
Financial performance and position
| Metric | Q2 2013 | Q2 2012 | Six months 2013 | Six months 2012 |
|---|---|---|---|---|
| Revenue | $1.118 million | $2.435 million | $2.435 million | $3.949 million |
| Gross profit / margin | $403,386 / 36.1% | $716,730 / 29.4% | $916,450 / 37.6% | $1,249,418 / 31.6% |
| Operating income (loss) | $(138,451) | $49,877 | $(191,973) | $25,836 |
| Net income (loss) | $(136,519) | $51,444 | $(188,660) | $28,894 |
| Net income (loss) per share | $(0.01) | $0.00 | $(0.02) | $0.00 |
For the first six months, operating cash flow was $(158,271), investing cash flow was $(22,669), and cash decreased by $180,940 to $2.442 million. At June 30, cash was $2.442 million, current assets $3.495 million, current liabilities $1.587 million, and stockholders’ equity $1.967 million. The company reported no non-current liabilities and no interest paid.
The company had no borrowings under its $1 million revolving credit line; $639,000 was available based on eligible accounts receivable. The line was due to expire December 1, 2013. Accounts receivable was $744,287 and deferred revenue was $284,710 at quarter-end.
Material changes versus the prior comparable periods
- Q2 revenue fell 54.1%; first-half revenue fell 38.3%. Professional-fee revenue declined 34.0% in Q2 and 17.7% for the half-year.
- Software product and maintenance revenue declined 79.6% in Q2 and 75.0% for the half-year, reflecting expiring federal maintenance contracts and lower product sales.
- Gross margin percentage improved year over year, but gross profit dollars declined as revenue contracted. Management attributed lower professional-services margins to the loss or funding reduction of higher-margin contracts, contract phase changes, and a shift toward hourly billing.
- SG&A excluding commissions declined 5.6% in Q2 but rose 2.3% for the first half. The company moved from modest net income in 2012 to net losses in both 2013 comparison periods.
Outlook, risks, and other items
Management stated that existing cash and its operating plan should meet cash requirements for the next twelve months and beyond. It reported no material capital expenditure commitments and no off-balance-sheet arrangements. No specific revenue or earnings guidance was provided.
Management said new contracts had not kept pace with contract expirations. Four customers represented 73.3% of Q2 revenue and 73.8% of first-half revenue, including direct and subcontracted federal-government work. Key risks include federal funding and contracting changes, customer and contract concentration, competition, technology changes, contract cost or schedule estimates, dependence on key personnel and third-party software suppliers, and sales volatility. Federal contract billings may be subject to DCAA audit; management considered the risk of a material financial-statement impact minimal. Legal proceedings were reported as none, and the company disclosed no material changes to its previously reported risk factors.
Disclosure controls were assessed as effective as of June 30, 2013; no material change in internal control over financial reporting was reported. The company amended an employee note receivable during the first half, advancing additional principal and extending maturity to January 25, 2017.
Important facts for investors to verify
- Confirm that the filing is for the intended issuer: the supplied document names Information Analysis Incorporated, not Firefly Neuroscience, Inc.
- Assess whether contract renewals and new awards can offset expirations, funding reductions, and the steep decline in software sales.
- Review the four-customer revenue concentration and the timing and funding status of government and subcontracted work.
- Confirm renewal or replacement terms for the revolving credit line expiring December 1, 2013, and the basis for the stated $639,000 availability.
- Monitor operating cash use and management’s ability to achieve its stated liquidity outlook.